Success Stories
Highlights of the PCI news focused on Penn commercialization accomplishments
Penn launches $750M investment in science, engineering, and medicine
President Amy Gutmann has announced the launch of a $750 million investment.
Pennovation Works Celebrates Five Years
November 8, 2021 marked the fifth anniversary of Pennovation Works, Penn’s business incubator and laboratory space.
Celebrating five years of innovation, entrepreneurship, and creativity
Penn Today marks the anniversary of Pennovation Works with a look at the evolution of the site, its research and commercialization achievements, and a glimpse into the future.
Success stories in gene therapy
Scientific American recently featured four stories on advancements in gene therapy.
Updated PCI Ventures Flagship Programs announced
PCI Ventures updated its flagship programs this past year that support University startups.
Interius BioTherapeutics Moves to Pennovation Lab
In October 2021, Interius BioTherapeutics (“Interius”) signed a 17,743 SF lease advancing cell and gene therapy research at the Pennovation Works innovation ecosystem.
Penn inventors make the mRNA-based COVID vaccines possible
Drew Weissman, MD, PhD, the Roberts Family Professor of Vaccine Research, and Katalin Karikó, PhD, an adjunct professor of Neurosurgery at Penn, have been awarded multiple prestigious prizes.
Philly just ranked high on a global list of startup ecosystems. These local leaders aren’t surprised
iladelphia landed a spot in the overall top 30 of Startup Genome's Global Startup Ecosystem Report. The city scored highest for its market reach and talent.
At-home COVID-19 results with the click of a smartphone
chers have developed a highly-sensitive rapid antigen test that can detect small loads of SARS-CoV-2
Recupero Robotics launches
Dr. Johnson and a team of collaborators have launched Recupero Robotics with the help of PCI Ventures.